Search research articles
Contact Us
Filters
Showing results (721-730 of 1,048) with videos related to
Page
of 105
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
April 7, 2018
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis
Sarah M Planchon, Karen T Lingas, Jane Reese Koç, et al.
The New England Journal of Medicine
|
April 13, 2000
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group
E A Stadtmauer, A O'Neill, L J Goldstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 5, 2015
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment
Manuel Afable, Paolo F Caimi, Chitra Hosing, et al.
Contemporary Clinical Trials
|
August 21, 2007
Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation
P Fu, W J van Heeckeren, P D Wadhwa, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 16, 2019
Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies
Robert J Kaner, Ednan K Bajwa, Moustapha El-Amine, et al.
Leukemia & Lymphoma
|
December 29, 2004
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995)
Peter A Cassileth, Sandra J Lee, Mark R Litzow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 31, 2004
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality
Punit D Wadhwa, Pingfu Fu, Omer N Koc, et al.
Stem Cells International
|
March 1, 2016
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
Morgan T Sutton, David Fletcher, Santosh K Ghosh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 4, 2015
Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial
Richard T Maziarz, Timothy Devos, Carlos R Bachier, et al.
Stem Cells (Dayton, Ohio)
|
July 13, 2021
Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity
Leland Metheny, Saada Eid, Patiwet Wuttisarnwattana, et al.
Page
of 105
Search research articles
Search
Showing results (721-730 of 1,048) with videos related to
Sort By:
Page
of 105
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
April 7, 2018
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis
Sarah M Planchon, Karen T Lingas, Jane Reese Koç, et al.
The New England Journal of Medicine
|
April 13, 2000
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group
E A Stadtmauer, A O'Neill, L J Goldstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 5, 2015
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment
Manuel Afable, Paolo F Caimi, Chitra Hosing, et al.
Contemporary Clinical Trials
|
August 21, 2007
Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation
P Fu, W J van Heeckeren, P D Wadhwa, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 16, 2019
Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies
Robert J Kaner, Ednan K Bajwa, Moustapha El-Amine, et al.
Leukemia & Lymphoma
|
December 29, 2004
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995)
Peter A Cassileth, Sandra J Lee, Mark R Litzow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 31, 2004
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality
Punit D Wadhwa, Pingfu Fu, Omer N Koc, et al.
Stem Cells International
|
March 1, 2016
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
Morgan T Sutton, David Fletcher, Santosh K Ghosh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 4, 2015
Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial
Richard T Maziarz, Timothy Devos, Carlos R Bachier, et al.
Stem Cells (Dayton, Ohio)
|
July 13, 2021
Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity
Leland Metheny, Saada Eid, Patiwet Wuttisarnwattana, et al.
Page
of 105